Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | Iterum Therapeutics plc ITRM | Point72 Asset Management, L.P. | 0 0.000% | -850,001![]() (Position Closed) | Filing History |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 46,685 0.100% | -2,970,408![]() (-98.45%) | Filing History |
| 2024-11-14 7:53 pm Sale | 2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 2,709,292 3.000% | -1,723,310![]() (-38.88%) | Filing History |
| 2024-11-14 7:53 pm Purchase | 2024-09-30 | 13G | Lumentum Holdings Inc. LITE | Point72 Asset Management, L.P. | 4,271,830 6.300% | 889,432![]() (+26.30%) | Filing History |
| 2024-11-14 7:53 pm Purchase | 2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 1,760,207 9.600% | 1,002,022![]() (+132.16%) | Filing History |
| 2024-11-14 7:53 pm Sale | 2024-09-30 | 13G | C4 Therapeutics, Inc. CCCC | Point72 Asset Management, L.P. | 1,313,747 1.900% | -1,362,949![]() (-50.92%) | Filing History |
| 2024-11-14 7:53 pm Purchase | 2024-09-30 | 13G | Avid Bioservices, Inc. CDMO | Point72 Asset Management, L.P. | 5,282,640 8.300% | 2,056,634![]() (+63.75%) | Filing History |
| 2024-11-14 7:52 pm Sale | 2024-09-30 | 13G | Morphic Holding, Inc. MORF | Point72 Asset Management, L.P. | 0 0.000% | -4,591,000![]() (Position Closed) | Filing History |
| 2024-11-14 7:51 pm Sale | 2024-09-30 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 619,020 1.000% | -3,540,434![]() (-85.12%) | Filing History |
| 2024-11-14 7:51 pm Purchase | 2024-09-30 | 13G | Cybin Inc. CYBN | Point72 Asset Management, L.P. | 292,397 1.400% | 292,397![]() (New Position) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 247,055 0.200% | -4,620,651![]() (-94.92%) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Point72 Asset Management, L.P. | 500,000 0.800% | -3,540,000![]() (-87.62%) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | Fate Therapeutics, Inc. FATE | Point72 Asset Management, L.P. | 0 0.000% | -4,945,146![]() (Position Closed) | Filing History |
| 2024-11-14 7:49 pm Sale | 2024-09-30 | 13G | TPI Composites, Inc. TPICQ | Point72 Asset Management, L.P. | 931,606 2.000% | -2,354,716![]() (-71.65%) | Filing History |
| 2024-11-14 7:49 pm Sale | 2024-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Point72 Asset Management, L.P. | 3,687,127 2.600% | -2,959,888![]() (-44.53%) | Filing History |
| 2024-11-14 7:49 pm Purchase | 2024-09-30 | 13G | PagSeguro Digital Ltd. PAGS | Point72 Asset Management, L.P. | 15,861,279 7.600% | 4,927,669![]() (+45.07%) | Filing History |
| 2024-11-14 7:48 pm Sale | 2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA | Point72 Asset Management, L.P. | 0 0.000% | -60,606![]() (Position Closed) | Filing History |
| 2024-11-14 7:48 pm Sale | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Point72 Asset Management, L.P. | 0 0.000% | -388,676![]() (Position Closed) | Filing History |
| 2024-11-14 7:47 pm Sale | 2024-09-30 | 13G | Pulmonx Corporation LUNG | Point72 Asset Management, L.P. | 0 0.000% | -1,936,083![]() (Position Closed) | Filing History |
| 2024-11-14 7:47 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Point72 Asset Management, L.P. | 1,684,032 2.500% | -1,072,090![]() (-38.90%) | Filing History |

